Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.02
HMA's Cash to Debt is ranked lower than
55% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 0.28 vs. HMA: 0.02 )
HMA' s 10-Year Cash to Debt Range
Min: 0.01   Max: 1.32
Current: 0.02

0.01
1.32
Equity to Asset 0.15
HMA's Equity to Asset is ranked lower than
51% of the 233 Companies
in the Global Medical Care industry.

( Industry Median: 0.47 vs. HMA: 0.15 )
HMA' s 10-Year Equity to Asset Range
Min: 0.02   Max: 0.77
Current: 0.15

0.02
0.77
Interest Coverage 0.88
HMA's Interest Coverage is ranked lower than
54% of the 156 Companies
in the Global Medical Care industry.

( Industry Median: 6.48 vs. HMA: 0.88 )
HMA' s 10-Year Interest Coverage Range
Min: 0.88   Max: 49.19
Current: 0.88

0.88
49.19
F-Score: 4
Z-Score: 1.38
M-Score: -2.72
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 4.67
HMA's Operating margin (%) is ranked higher than
60% of the 230 Companies
in the Global Medical Care industry.

( Industry Median: 9.71 vs. HMA: 4.67 )
HMA' s 10-Year Operating margin (%) Range
Min: 4.67   Max: 20.32
Current: 4.67

4.67
20.32
Net-margin (%) 2.56
HMA's Net-margin (%) is ranked higher than
66% of the 230 Companies
in the Global Medical Care industry.

( Industry Median: 4.97 vs. HMA: 2.56 )
HMA' s 10-Year Net-margin (%) Range
Min: 2.56   Max: 12.09
Current: 2.56

2.56
12.09
ROE (%) 15.33
HMA's ROE (%) is ranked higher than
87% of the 223 Companies
in the Global Medical Care industry.

( Industry Median: 9.92 vs. HMA: 15.33 )
HMA' s 10-Year ROE (%) Range
Min: 7.6   Max: 147.95
Current: 15.33

7.6
147.95
ROA (%) 2.35
HMA's ROA (%) is ranked higher than
65% of the 231 Companies
in the Global Medical Care industry.

( Industry Median: 3.98 vs. HMA: 2.35 )
HMA' s 10-Year ROA (%) Range
Min: 2.35   Max: 14.75
Current: 2.35

2.35
14.75
ROC (Joel Greenblatt) (%) 7.05
HMA's ROC (Joel Greenblatt) (%) is ranked higher than
60% of the 230 Companies
in the Global Medical Care industry.

( Industry Median: 17.97 vs. HMA: 7.05 )
HMA' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 7.05   Max: 34.44
Current: 7.05

7.05
34.44
Revenue Growth (%) 7.40
HMA's Revenue Growth (%) is ranked higher than
75% of the 182 Companies
in the Global Medical Care industry.

( Industry Median: 7.10 vs. HMA: 7.40 )
HMA' s 10-Year Revenue Growth (%) Range
Min: 3.5   Max: 46.1
Current: 7.4

3.5
46.1
EBITDA Growth (%) -3.70
HMA's EBITDA Growth (%) is ranked higher than
60% of the 164 Companies
in the Global Medical Care industry.

( Industry Median: 7.20 vs. HMA: -3.70 )
HMA' s 10-Year EBITDA Growth (%) Range
Min: -4.7   Max: 47.9
Current: -3.7

-4.7
47.9
EPS Growth (%) 4.60
HMA's EPS Growth (%) is ranked higher than
69% of the 145 Companies
in the Global Medical Care industry.

( Industry Median: 9.80 vs. HMA: 4.60 )
HMA' s 10-Year EPS Growth (%) Range
Min: -28.1   Max: 47
Current: 4.6

-28.1
47
» HMA's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2013

HMA Guru Trades in Q1 2013

John Hussman 1,650,000 sh (New)
Ray Dalio 151,526 sh (New)
HOTCHKIS & WILEY 5,436,100 sh (+159.41%)
Joel Greenblatt 276,125 sh (+107.43%)
Jeremy Grantham 87,229 sh (+17.21%)
Larry Robbins 37,757,583 sh (+7.7%)
Jeff Auxier 537,442 sh (+0.26%)
Vanguard Health Care Fund 15,656,900 sh (unchged)
Private Capital Sold Out
Columbia Wanger 3,128,400 sh (-1.88%)
Richard Snow 4,445,549 sh (-6.54%)
Steven Cohen 19,169 sh (-99.37%)
» More
Q2 2013

HMA Guru Trades in Q2 2013

Steven Cohen 52,689 sh (+174.87%)
Vanguard Health Care Fund 19,140,500 sh (+22.25%)
Jeff Auxier 544,342 sh (+1.28%)
Larry Robbins 37,757,583 sh (unchged)
Louis Moore Bacon 150,000 sh (unchged)
Ray Dalio Sold Out
John Hussman Sold Out
Columbia Wanger Sold Out
Jeremy Grantham 80,417 sh (-7.81%)
Richard Snow 3,983,944 sh (-10.38%)
Joel Greenblatt 179,815 sh (-34.88%)
HOTCHKIS & WILEY 2,612,200 sh (-51.95%)
» More
Q3 2013

HMA Guru Trades in Q3 2013

Jean-Marie Eveillard 475,000 sh (New)
Lee Ainslie 2,204,958 sh (New)
Mario Gabelli 14,800 sh (New)
John Hussman 1,000,000 sh (New)
Jeremy Grantham 1,776,267 sh (+2108.82%)
Larry Robbins 37,757,583 sh (unchged)
Jeff Auxier 544,342 sh (unchged)
Vanguard Health Care Fund 18,834,700 sh (-1.6%)
Joel Greenblatt 147,073 sh (-18.21%)
Richard Snow 3,256,589 sh (-18.26%)
HOTCHKIS & WILEY 478,400 sh (-81.69%)
Steven Cohen 5,900 sh (-88.8%)
» More
Q4 2013

HMA Guru Trades in Q4 2013

Mario Gabelli 29,100 sh (+96.62%)
Vanguard Health Care Fund 18,834,700 sh (unchged)
HOTCHKIS & WILEY 478,400 sh (unchged)
Larry Robbins 37,757,583 sh (unchged)
Steven Cohen Sold Out
Jean-Marie Eveillard Sold Out
Richard Snow Sold Out
Lee Ainslie Sold Out
John Hussman Sold Out
Jeff Auxier 536,042 sh (-1.52%)
Jeremy Grantham 1,302,300 sh (-26.68%)
Joel Greenblatt 32,497 sh (-77.9%)
» More
» Details

Insider Trades

Latest Guru Trades with HMA

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
John Hussman 2013-12-31 Sold Out 0.7%$12.16 - $13.24 $ 13.323%0
Lee Ainslie 2013-12-31 Sold Out 0.38%$12.16 - $13.24 $ 13.323%0
Joel Greenblatt 2013-12-31 Reduce -77.9%0.05%$12.16 - $13.24 $ 13.323%32497
Jean-Marie Eveillard 2013-12-31 Sold Out 0.02%$12.16 - $13.24 $ 13.323%0
Mario Gabelli 2013-12-31 Add 96.62%$12.16 - $13.24 $ 13.323%29100
John Hussman 2013-09-30 New Buy0.7%$12.58 - $16.94 $ 13.32-4%1000000
Lee Ainslie 2013-09-30 New Buy0.38%$12.58 - $16.94 $ 13.32-4%2204958
Jean-Marie Eveillard 2013-09-30 New Buy0.02%$12.58 - $16.94 $ 13.32-4%475000
Mario Gabelli 2013-09-30 New Buy$12.58 - $16.94 $ 13.32-4%14800
John Hussman 2013-06-30 Sold Out 0.78%$10.38 - $16.32 $ 13.326%0
Vanguard Health Care Fund 2013-06-30 Add 22.25%0.2%$10.38 - $16.32 $ 13.326%19140500
Joel Greenblatt 2013-06-30 Reduce -34.88%0.06%$10.38 - $16.32 $ 13.326%179815
Ray Dalio 2013-06-30 Sold Out 0.02%$10.38 - $16.32 $ 13.326%0
John Hussman 2013-03-31 New Buy0.78%$9.12 - $12.91 $ 13.3224%1650000
Joel Greenblatt 2013-03-31 Add 107.43%0.09%$9.12 - $12.91 $ 13.3224%276125
Ray Dalio 2013-03-31 New Buy0.02%$9.12 - $12.91 $ 13.3224%151526
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 3.48
HMA's P/B is ranked higher than
54% of the 223 Companies
in the Global Medical Care industry.

( Industry Median: 2.28 vs. HMA: 3.48 )
HMA' s 10-Year P/B Range
Min: 1.08   Max: 38.45
Current: 3.48

1.08
38.45
P/S 0.59
HMA's P/S is ranked higher than
82% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 1.37 vs. HMA: 0.59 )
HMA' s 10-Year P/S Range
Min: 0.06   Max: 2.6
Current: 0.59

0.06
2.6
EV-to-EBIT -307.39
HMA's EV-to-EBIT is ranked lower than
80% of the 200 Companies
in the Global Medical Care industry.

( Industry Median: 17.77 vs. HMA: -307.39 )
HMA' s 10-Year EV-to-EBIT Range
Min: 8.3   Max: 52.6
Current: -307.39

8.3
52.6
Shiller P/E 25.09
HMA's Shiller P/E is ranked higher than
64% of the 106 Companies
in the Global Medical Care industry.

( Industry Median: 24.97 vs. HMA: 25.09 )
HMA' s 10-Year Shiller P/E Range
Min: 0.94   Max: 31.34
Current: 25.09

0.94
31.34

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 1.42
HMA's Price/DCF (Projected) is ranked higher than
57% of the 130 Companies
in the Global Medical Care industry.

( Industry Median: 1.22 vs. HMA: 1.42 )
HMA' s 10-Year Price/DCF (Projected) Range
Min: 0.19   Max: 45.25
Current: 1.42

0.19
45.25
Price/Median PS Value 1.19
HMA's Price/Median PS Value is ranked higher than
61% of the 214 Companies
in the Global Medical Care industry.

( Industry Median: 1.10 vs. HMA: 1.19 )
HMA' s 10-Year Price/Median PS Value Range
Min: 0.2   Max: 10.77
Current: 1.19

0.2
10.77
Earnings Yield (Greenblatt) 4.80
HMA's Earnings Yield (Greenblatt) is ranked higher than
66% of the 222 Companies
in the Global Medical Care industry.

( Industry Median: 5.30 vs. HMA: 4.80 )
HMA' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.9   Max: 12
Current: 4.8

1.9
12
Forward Rate of Return (Yacktman) -2.95
HMA's Forward Rate of Return (Yacktman) is ranked higher than
57% of the 171 Companies
in the Global Medical Care industry.

( Industry Median: 11.19 vs. HMA: -2.95 )
HMA' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -0.5   Max: 66
Current: -2.95

-0.5
66

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:HMG.Germany
Health Management Associates, Inc. was incorporated in Delaware in 1979 but began operations through a subsidiary that was formed in 1977. It became a public company in 1991. As of December 31, 2011, it operated 66 hospitals with a total of 10,330 licensed beds in Alabama, Arkansas, Florida, Georgia, Kentucky, Mississippi, Missouri, North Carolina, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Washington and West Virginia. The Company and its subsidiaries provide health care services to patients in owned and leased facilities located mainly in non-urban communities in the southeastern and southwestern United States. Services provided by its hospitals include general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care and pediatric services. It also provides outpatient services such as one-day surgery, laboratory, x-ray, respiratory therapy, cardiology and physical therapy. Additionally, some of the Company's hospitals provide specialty services in, among other areas, cardiology e.g., open-heart surgery, etc., neuro-surgery, oncology, radiation therapy, computer-assisted tomography 'CT' scanning, magnetic resonance imaging 'MRI', lithotripsy and full-service obstetrics.The Company's strategy is to deliver health care services and improve patient and physician satisfaction, improve operations of its hospitals, utilize efficient management and acquire strategic hospitals in non-urban communities. In many of the geographic areas where it operates, there are other hospitals that provide services comparable to those offered by its hospitals. The Company is subject to compliance with various federal, state and local environmental laws, rules and regulations, including, but not limited to, the disposal of medical waste generated by its operations.

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide